<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1053</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2019-3-34-39</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Review of PIC/S guidance on classification of GMP deficiencies</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Orlov</surname><given-names>V. A.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Federal State Budgetary Institution «State Institute of Medicines and Good Practices»</aff><aff id="aff-2">Federal State Budget Educational Institution of Higher Education «Saint Petersburg State Chemical Pharmaceutical Academy»</aff><pub-date date-type="epub" iso-8601-date="2019-12-03" publication-format="electronic"><day>03</day><month>12</month><year>2019</year></pub-date><issue>3</issue><fpage>34</fpage><lpage>39</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2019,</copyright-statement><copyright-year>2019</copyright-year></permissions><abstract>The article provides an overview of the PIC/S (PI 040-1) guidance published in January 2019, which contains recommendations on classification of identified GMP deficiencies. It provides detailed diagrams containing instructions on the recommended operating procedures in case of identification of GMP deficiencies, and decision versions of final classification of such deficiencies. In addition, the authors provide regulators with valuable recommendations on the management of possible activities in response to critical and significant GMP deficiencies.</abstract><kwd-group xml:lang="en"><kwd>PIC/S</kwd><kwd>GMP deficiencies</kwd><kwd>inspection of pharmaceutical manufacturers</kwd><kwd>drug quality</kwd><kwd>harmonization of regulatory requirements</kwd><kwd>data integrity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>несоответствие требованиям GMP</kwd><kwd>инспектирование фармацевтического производства</kwd><kwd>качество лекарственных средств</kwd><kwd>гармонизация регуляторных требований</kwd><kwd>целостность данны</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Орлов В.А., Шестаков В.Н. Проблемы классификации несоответствий требованиям GMP: регуляторный опыт. Ремедиум. Журнал о российском рынке лекарств и медицинской техники. 2019;1:18-24.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Risk classification guide for drug good manufacturing practices observations // Health Canada URL: https://www.canada.ca/ content/dam/hc-sc/documents/services/drugs-health-products/ compliance-enforcement/good-manufacturing-practices/ guidance-documents/risk-classification-drug-gmp-observations-0023-eng.pdf (дата обращения: 24.02.2019).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>PIC/S guidance on classification of GMP deficiencies // The Pharmaceutical Inspection Co-operation Scheme (PIC/S) URL: https://picscheme.org/layout/document.php?id=1609 (дата обращения: 24.02.2019).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>PIC/S inspection report format // Pharmaceutical Inspection Co-operation Scheme URL: https://picscheme.org/layout/ document.php?id=137 (дата обращения: 24.02.2019).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Compilation of Community Procedures on Inspections and Exchange of Information // European Comission URL: https:// www.ema.europa.eu/documents/regulatory-procedural-guideline/ compilation-community-procedures-inspections-exchange-information_en.pdf (дата обращения: 24.02.2019).</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Good practices for data management and integrity in regulated GMP/GDP environments (Draft) // Pharmaceutical Inspection Co-operation Scheme URL: https://picscheme.org/layout/ document.php?id=1567 (дата обращения: 24.02.2019).</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Deviation Handling and Quality Risk Management (Draft) // World Health Organization uRL: https://www.who.int/ immunization_standards/vaccine_quality/risk_july_2013.pdf?ua=1 (дата обращения: 24.02.2019).</mixed-citation></ref></ref-list></back></article>
